In-Depth Examination Of 10 Analyst Recommendations For Moderna
In-Depth Examination Of 10 Analyst Recommendations For Moderna
对现代a的10个分析师建议进行深入探讨
10 analysts have expressed a variety of opinions on Moderna (NASDAQ:MRNA) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在过去的季度中，有10位分析师对Moderna（纳斯达克: MRNA）表示了各种观点，提供了从看好到看淡的多元化观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $147.3, a high estimate of $214.00, and a low estimate of $106.00. This current average has increased by 4.01% from the previous average price target of $141.62.
经过分析师的分析，12个月的目标价格提供了洞察力，平均目标为147.3美元，最高估价为214.00美元，最低估价为106.00美元。 当前平均价值已从141.62美元的前一个平均目标上升了4.01%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
An in-depth analysis of recent analyst actions unveils how financial...
对最近分析师行动进行深...
登录免费看全文
登录/注册